[Federal Register: April 7, 2003 (Volume 68, Number 66)]
[Notices]
[Page 16803-16804]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr07ap03-70]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Prospective Grant of Exclusive License: Diagnostics of Fungal
Infections
AGENCY: Technology Transfer Office, Centers for Disease Control and
Prevention (CDC), Department of Health and Human Services.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37
CFR 404.7(a)(1)(i) that the Centers for Disease Control and Prevention
(CDC), Technology Transfer Office, Department of Health and Human
Services (DHHS), is contemplating the grant of a worldwide, limited
field of use, exclusive license to practice the inventions embodied in
the patent and patent applications referred to below to Transgenomic,
Inc. (Transgenomic) having a place of business in Omaha, Nebraska. The
patent rights in these inventions have been assigned to the government
of the United States of America. The patent and patent applications to
be licensed are:
Title: Rapid and Sensitive Method for Detecting Histoplasma
capsulatum.
U.S. Patent Application Serial No.: 09/673,298.
Filing Date: 1/12/2001.
Domestic Status: Patent No.: 6,469,156.
Issue Date: 10/22/2002.
Title: Nucleic Acids for Detecting Aspergillus Species and Other
Filamentous Fungi.
U.S. Patent Application Serial No.: 09/423,233.
Filing Date: 6/27/2000.
Domestic Status: 6,372,430.
Issue Date: 4/16/2002.
Title: Molecular Identification of Aspergillus Species.
U.S. Patent Application Serial No.: 60/381,463.
Filing Date: 5/17/2002.
Domestic Status: Pending.
Issue Date: N/A.
Title: Nucleic Acids for the Identification of Fungi and Methods
for Using the Same.
U.S. Patent Application Serial No.: 60/325,241.
Filing Date: 9/26/2001.
Domestic Status: Pending.
Issue Date: N/A.
Title: Nucleic Acids of the M Antigen Gene of Histoplasma
Capsulatum, Antigens, Vaccines, and Antibodies.
U.S. Patent Application Serial No.: 09/674,195.
Filing Date: 10/10/2000.
Domestic Status: Pending.
Issue Date: N/A.
Title: Nucleic Acids for Detecting Fusarium Species and Other
Filamentous Fungi.
U.S. Patent Application Serial No.: 10/046,955.
Filing Date: 1/14/2002.
Domestic Status: Pending.
Issue Date: N/A.
Title: Nucleic Acid Probes for Detecting Candida Species.
U.S. Patent Application Serial No.: 08/903,446.
Filing Date: 7/30/1997.
Domestic Status: 6,242,178.
Issue Date: 6/5/2001.
Title: Nucleic Acid Probes for Candida Parapsilosis Methods for
Detecting Candidiasis in Blood.
U.S. Patent Application Serial No.: 08/429,520.
Filing Date: 4/26/1995.
Domestic Status: 5,688,644.
Issue Date: 11/18/1997.
Title: Nucleic Acid Sequences and Methods for Detecting Candida
tropicalis in Blood.
U.S. Patent Application Serial No.: 08/429,522.
Filing Date: 4/26/1995.
Domestic Status: 5,645,992.
Issue Date: 7/8/1997.
Title: Nucleic Acid Probes and Methods for Detecting Candida krusei
Cells in Blood.
U.S. Patent Application Serial No.: 08/429,532.
Filing Date: 4/26/1995.
Domestic Status: 5,635,353.
Issue Date: 6/3/1997.
Title: Nucleic Acid Probes and Methods for Detecting Candida
glabrata DNA in Blood.
U.S. Patent Application Serial No.: 08/429,523.
Filing Date: 4/26/1995.
Domestic Status: 5,631,132.
[[Page 16804]]
Issue Date: 5/20/1997.
Title: Nucleic Acid Probes and Methods for Detecting Candida DNA
Cells in Blood.
U.S. Patent Application Serial No.: 08/065,845.
Filing Date: 5/20/1993.
Domestic Status: 5,426,027.
Issue Date: 6/20/1995.
The prospective exclusive license will be royalty-bearing and will
comply with the terms and conditions of 35 U.S.C. 209 and 37 CFR 404.7.
Specific DNA (oligonucleotide) probes have been developed for a
wide variety of systemic disease causing fungi, including Histoplasma
capsulatum, Aspergillus species, Candida species, Fusarium species, and
others. A probe has been developed for identification of all dimorphic
fungi. These probes can be used for the rapid identification of fungal
pathogens and for the diagnosis of mycotic diseases.
ADDRESSES: Requests for a copy of these patent applications, inquiries,
comments, and other materials relating to the contemplated license
should be directed to Andrew Watkins, Director, Technology Transfer
Office, Centers for Disease Control and Prevention (CDC), 4770 Buford
Highway, Mailstop K-79, Atlanta, GA 30341, telephone: (770) 488-8610;
facsimile: (770) 488-8615. Applications for a license filed in response
to this notice will be treated as objections to the grant of the
contemplated license. Only written comments and/or applications for a
license which are received by CDC within sixty days of this notice will
be considered. Comments and objections submitted in response to this
notice will not be made available for public inspection, and to the
extent permitted by law, will not be released under the Freedom of
Information Act, 5 U.S.C. 552. A signed Confidential Disclosure
Agreement will be required to receive a copy of any pending patent
application.
Dated: March 31, 2003.
James D. Seligman,
Associate Director for Program Services, Centers for Disease Control
and Prevention (CDC).
[FR Doc. 03-8322 Filed 4-4-03; 8:45 am]
BILLING CODE 4163-18-P